The National Headache Foundation, helmed by Whiting-Robertsdale Chamber of Commerce Vice President and Pierogi Fest Co-Founder Tom Dabertin, reformatted its original educational programming that s now known as HeadWise.
can offer something different, pain relief without constricted the blood vessels. this medication seems to do this in early trials. that s what people are talking about in the headache community. sanjay, what do you think the chances are that this drug is going to get approval? it is not even being tested here, is it? it is hard to say how long it will take to get approval. what s interesting is the third thing, side effects. in some of the early trials, some patients developed liver problems. the liver enzymes went up. if this is toxic to the liver, it may never hit the market. you build on that learning to try and make a better drug with fewer side effects. it is hard to say at this point when or if it will hit the market. when you get sidelined with a